Transplant glomerulopathy: subclinical incidence and association with alloantibody. - Wikidata - wikimedia - TriplyDB

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

http://www.wikidata.org/entity/Q53543179

about

The importance of C4d in biopsies of kidney transplant recipients Effector mechanisms of rejection An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies.The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.Results of gal-knockout porcine thymokidney xenografts.Renal transplantation in patients with hepatitis C virus antibody. A long national experience.Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathy Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy Diagnosis and management of antibody-mediated rejection: current status and novel approaches.Quantifying renal allograft loss following early antibody-mediated rejection.Antibodies reactive to non-HLA antigens in transplant glomerulopathy Experimental glomerular endothelial injury in vivo Emerging role of B cells in chronic allograft dysfunction.Late kidney allograft loss: what we know about it, and what we can do about it The two kidney to one kidney transition and transplant glomerulopathy: a podocyte perspective Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians Antibody-mediated rejection of single class I MHC-disparate cardiac allografts.The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation.Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection.C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.Chronic alloantibody mediated rejection.Transplant glomerulopathy.The spectrum of antibody-mediated renal allograft injury: implications for treatment.The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure.Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys Identification and characterization of kidney transplants with good glomerular filtration rate at 1 year but subsequent progressive loss of renal function.Antibody-Mediated Rejection: A Review.Capillary dilation and rarefaction are correlated with intracapillary inflammation in antibody-mediated rejection.Chronic viral hepatitis in kidney transplantation.Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants.Current problems of chronic active antibody-mediated rejection.Surveillance biopsies in children post-kidney transplant.Surveillance protocol kidney transplant biopsies: their evolving role in clinical practice.Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale.The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.Phenotypes of antibody-mediated rejection in organ transplants.

P2860

Q27021227-71471E0E-15BA-44A0-A063-821B2A348080 Q27027082-30FB8389-22B3-47B5-9FB9-D7489EF3204E Q33414342-495FBA28-C2E7-4097-BA7F-F65C4D9E2CC3 Q33426548-EE0FB0E9-997D-4E3F-9BA0-DB0ACA9AA8D7 Q33571091-FC2C12CE-7B15-4A45-88D1-4311177FFC5B Q33871282-1E9FC1E3-BD9D-488B-8715-EBC6D799F484 Q34084853-ECA402C1-C180-45B2-957C-B9F89E1AD90D Q34124202-7F50B252-BD85-4264-8B58-1160CE04FB03 Q34423734-14BA593A-4316-4399-94E1-693E9B869B3E Q34839515-8FDD1D00-936B-4E64-95D3-B9041A60931A Q34841849-1A414F59-5030-4115-9045-11361B0EA03B Q35007419-A18DA175-8276-4E90-ABF1-446973E6C865 Q35012455-525818BC-AA85-4794-8C4B-AEE7030AE4C0 Q35021857-D4AAC496-1397-4814-AD27-2B638080FF86 Q35124576-30DB6223-104F-4987-B157-72D5390F50BD Q35153318-F033D506-1626-45CA-9491-25A71978EBB5 Q35658590-18D4AC9D-0D8C-4872-AF98-93F93122EF34 Q36007256-87FEDD64-FA57-409A-AB3C-ABA7474D0BAC Q36131185-8BB2BB6E-0D67-40CF-9300-CA6D930E5346 Q36240178-446CEF17-8E31-41FA-A018-768878A28E2F Q36677655-1AFC016F-28E3-46CB-BFD7-7F77CACB2751 Q37042154-0CD5A680-E5A1-478A-9777-933D16DDF599 Q37058039-8BCBF1EF-5339-49AD-9493-C67C3FBD8E94 Q37058050-CFF1AC04-57F6-4B2C-B493-BC0F1263A574 Q37092282-121D099F-4EB9-4C9A-B541-41F4B9C55ABF Q37176570-3512DB41-B842-44F0-8FEC-3E356CA9FC14 Q37359074-88297E6A-9453-4C14-ADC6-3AABB8578BC1 Q37367683-4D015EEE-97D4-4F29-9A2C-84C68D68F85B Q37485481-D0498387-38AB-4F57-B206-7B4EAD2216DE Q37535280-CDAF8A89-845F-4ACB-ABB2-625742B8020D Q37698860-996149DD-0965-4F0C-BC55-7C5DEEA263A1 Q37704862-03A3603A-4653-4EC4-959A-1F5BBBA04975 Q37833898-23EB1F28-548A-4DAE-9E1E-B1A47E50064D Q37859066-B699EFD9-EFCD-4EA5-B2F1-56577D0F4AD5 Q37882017-32AA80C7-228E-46B8-95A5-803E663BC49D Q37906368-45B56A12-D3D9-4178-B150-BEB6C43E4DB8 Q37907391-232312E1-EE89-4B2F-818B-43B01CC3830E Q37990988-C9E77E8B-98CC-4615-9482-522D00D8A333 Q38003049-202F88A5-71CD-4327-8FCA-72282FE56F65 Q38005448-BE0BFCF5-513F-4668-AC29-322099A519B4

P2860

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

http://www.wikidata.org/entity/Q53543179

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

@en

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

@nl

type

label

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

@en

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

@nl

prefLabel

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

@en

Transplant glomerulopathy: subclinical incidence and association with alloantibody.

@nl

P1433

Q53543179-9E0333AE-CA95-47D4-A53B-896C8549D5B1

P1476

Q53543179-E8E6D680-0185-4585-BC2D-10674BBA0156

P2093

Q53543179-0D2D9476-F6E1-4F11-99C2-D4463E994086

Q53543179-369E568E-41AE-4A05-9EE1-1BD68361B4B8

Q53543179-5B72714D-40C7-4FD1-95A0-5BA7A41534F2

Q53543179-ABB72474-561C-419B-856A-C128E56F65DC

Q53543179-B8170116-C21A-4896-8CCF-C605D8459C46

Q53543179-BC7EA8A5-EF6C-4F6A-AB96-2C03E6C54804

Q53543179-D76AE42B-E469-490A-B700-00AF534F2A4F

Q53543179-E5101E71-1473-4470-8B66-40BD1492D4CA

P2860

Q53543179-039D7F29-8D64-4566-A4CE-AAC0B0C5CFE8

Q53543179-348F1F00-B3C8-4726-B293-AF3328E90D50

Q53543179-392EF921-E405-4840-B8DC-149B38CB749C

Q53543179-4D7A81E7-0CEE-44B3-94BA-13620EBF5338

Q53543179-5DEB5AC5-E32F-42D4-97E3-A0456FD8611C

Q53543179-8634CE24-1171-4DE6-8975-E937720FAB49

Q53543179-BDDD764A-721C-481E-8A11-09A6C12CE0CF

Q53543179-C4680B90-60F5-46C3-BAB6-4B11C8F13183

P304

Q53543179-DFE05D09-F3F4-45D7-B885-86225AE64EBF

P31

Q53543179-355C69C0-D821-4BD3-AE88-45A7DF75D7E2

P356

Q53543179-CD0535B0-71A7-4657-8A43-9F66F26EAB25

P407

Q53543179-E9A72B39-6B1C-450E-A41A-4EFE13F54518

P433

Q53543179-DA0727BC-4ED5-420E-BC67-404A81E7F5F3

P478

Q53543179-CEB4A128-7B17-4E53-A118-DB87B50B2FA6

P50

Q53543179-F5024C34-BC3E-4064-A06D-FC8BD73ABE10

P577

Q53543179-644AF004-203D-4635-BA7C-A25A7A377669

P5875

Q53543179-0FB21E48-DE73-4855-8C05-92CFE51D128B

P698

Q53543179-75EEB9FE-AAD9-48E9-BDE6-F11718DE178A

P356

J.1600-6143.2007.01895.X

P1433

American Journal of Transplantation

P1476

Transplant glomerulopathy: subclinical incidence and association with alloantibody

@en

P2093

Cosio FG

http://www.w3.org/2001/XMLSchema#string

DeGoey S

http://www.w3.org/2001/XMLSchema#string

Gloor JM

http://www.w3.org/2001/XMLSchema#string

Larson TS

http://www.w3.org/2001/XMLSchema#string

Moore SB

http://www.w3.org/2001/XMLSchema#string

Park WD

http://www.w3.org/2001/XMLSchema#string

Sethi S

http://www.w3.org/2001/XMLSchema#string

Stegall MD

http://www.w3.org/2001/XMLSchema#string

P2860

Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression.

Peritubular capillary basement membrane reduplication in allografts and native kidney disease: a clinicopathologic study of 278 consecutive renal specimens.

Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy.

Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.

The clinical impact of chronic transplant glomerulopathy in cyclosporine era.

Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy.

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

The Banff 97 working classification of renal allograft pathology

P304

2124-2132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-6143.2007.01895.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Matthew D Griffin

P577

2007-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6228578

http://www.w3.org/2001/XMLSchema#string

P698

17608832

http://www.w3.org/2001/XMLSchema#string